Sentral forskning

Vi gjør oppmerksom på at det kreves spesiell tilgang for å få opp fulltekst på noen av artiklene.

Medikamenter

British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids.
Russell, M. D., Dey, M., Flint, J., Davie, P., Allen, A., Crossley, A., Frishman, M., Gayed, M., Hodson, K., Khamashta, M., Moore, L., Panchal, S., Piper, M., Reid, C., Saxby, K., Schreiber, K., Senvar, N., Tosounidou, S., van de Venne, M., . . . Giles, I. (2022). Rheumatology (Oxford). https://doi.org/10.1093/rheumatology/keac551. PMID: 36318966

British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practice.
Schreiber, K., Frishman, M., Russell, M. D., Dey, M., Flint, J., Allen, A., Crossley, A., Gayed, M., Hodson, K., Khamashta, M., Moore, L., Panchal, S., Piper, M., Reid, C., Saxby, K., Senvar, N., Tosounidou, S., van de Venne, M., Warburton, L., . . . Giles, I. (2022). Rheumatology (Oxford). https://doi.org/10.1093/rheumatology/keac552. PMID: 36318967

Immunology of pregnancy and reproductive health in autoimmune rheumatic diseases. Update from the 11th International Conference on Reproduction, Pregnancy and Rheumatic Diseases.
Andreoli L, Chighizola CB, Iaccarino L, Botta A, Gerosa M, Ramoni V, Tani C, Bermas B, Brucato A, Buyon J, Cetin I, Chambers CD, Clowse MEB, Costedoat-Chalumeau N, Cutolo M, De Carolis S, Dolhain R, Fazzi EM, Förger F, Giles I, Haase I, Khamashta M, Levy RA, Meroni PL, Mosca M, Nelson-Piercy C, Raio L, Salmon J, Villiger P, Wahren-Herlenius M, Wallenius M, Zanardini C, Shoenfeld Y, Tincani A. Autoimmun Rev. 2022 Dec 20;22(3):103259. doi: 10.1016/j.autrev.2022.103259. Epub ahead of print. PMID: 36549355.

Analysing cord blood levels of TNF inhibitors to validate the EULAR points to consider for TNF inhibitor use during pregnancy. Ghalandari N, Kemper E, Crijns IH, Wolbink G, Rispens T, Smeele HT, Dolhain RJ.
Ann Rheum Dis. 2022 Mar;81(3):402-405. doi: 10.1136/annrheumdis-2021-221036. Epub 2021 Sep 7. PMID: 34493490.

Fetal and maternal outcomes after maternal biologic use during conception and pregnancy: A systematic review and meta-analysis.
O'Byrne, L. J., Alqatari, S. G., Maher, G. M., O'Sullivan, A. M., Khashan, A. S., Murphy, G. P., & McCarthy, F. P. (2022). Bjog, 129(8), 1236-1246. https://doi.org/10.1111/1471-0528.17093. PMID: 35014759.

2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases.
Arthritis Rheumatol. Sammaritano LR et al. 2020 Apr;72(4):529-556. doi: 10.1002/art.41191. Epub 2020 Feb 23. PMID: 32090480.

A systematic review of the safety of non-tumour necrosis factor inhibitor and targeted synthetic drugs in rheumatic disease in pregnancy.
Ahmed K et al. 2020 Mar;20(Suppl 2):s98. doi: 10.7861/clinmed.20-2-s98. PMID: 32409405; PMID: PMC7243518.

The effect of paternal exposure to immunosuppressive drugs on sexual function, reproductive hormones, fertility, pregnancy and offspring outcomes: a systematic review.
Perez-Garcia LF, Dolhain RJEM, Vorstenbosch S, Bramer W, van Puijenbroek E, Hazes JMW, Te Winkel B. Hum Reprod Update. 2020 Nov 1;26(6):961-1001. doi: 10.1093/humupd/dmaa022. PMID: 32743663; PMCID: PMC7600290.

The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation.
Götestam Skorpen C et al. Ann Rheum Dis. 2016 May;75(5):795-810. doi: 10.1136/annrheumdis-2015-208840. Epub 2016 Feb 17. PMID: 26888948.

BSR and BHPR Standards, Guidelines and Audit Working Group. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids.
Flint J et al. Rheumatology (Oxford). 2016 Sep;55(9):1693-7. doi: 10.1093/rheumatology/kev404. Epub 2016 Jan 10. PMID: 26750124.

BSR and BHPR Standards, Guidelines and Audit Working Group. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part II: analgesics and other drugs used in rheumatology practice.
Flint J et al. Rheumatology (Oxford). 2016 Sep;55(9):1698-702. doi: 10.1093/rheumatology/kev405. Epub 2016 Jan 10. PMID: 26750125.

Risk of Ocular Anomalies in Children Exposed In Utero to Antimalarials: A Systematic Literature Review.
Gaffar R et al. Arthritis Care Res (Hoboken). 2019 Dec;71(12):1606-1610. doi: 10.1002/acr.23808. PMID: 30418703.

Safety of anti-rheumatic drugs in men trying to conceive: A systematic review and analysis of published evidence.
Mouyis M et al. Semin Arthritis Rheum. 2019 Apr;48(5):911-920. doi: 10.1016/j.semarthrit.2018.07.011. Epub 2018 Aug 17. PMID: 30220537.

Bindevevssykdommer

Systemic Lupus Erythematosus Management in Pregnancy. Dao, K. H., & Bermas, B. L. (2022). Int J Womens Health, 14, 199-211. https://doi.org/10.2147/ijwh.S282604. PMID: 35210867.

Svangerskapskomplikasjoner hos kvinner med systemisk lupus erythematosus [Pregnancy complications in women with systemic lupus erythematosus].
Skorpen CG, Salvesen KÅB, Palm Ø, Radtke M, Wallenius M. Tidsskr Nor Laegeforen. 2021 May 25;141(8). Norwegian. doi: 10.4045/tidsskr.20.0596. PMID: 34047174.

Pregnancy outcomes in mixed connective tissue disease: a multicentre study.
Radin M, Schreiber K, Cuadrado MJ, Cecchi I, Andreoli L, Franceschini F, Caleiro T, Andrade D, Gibbone E, Khamashta M, Buyon J, Izmirly P, Aguirre MA, Benedetto C, Roccatello D, Marozio L, Sciascia S. Rheumatology (Oxford). 2019 Nov 1;58(11):2000-2008. doi: 10.1093/rheumatology/kez141. PMID: 31079145.

Pregnancy and undifferentiated connective tissue disease: outcome and risk of flare in 100 pregnancies. Zucchi D et al.
Rheumatology (Oxford). 2020 Jun 1;59(6):1335-1339. doi: 10.1093/rheumatology/kez440. PMID: 31593595.

Maternal and fetal complications associated with systemic lupus erythematosus: An updated meta-analysis of the most recent studies (2017-2019). He WR, Wei H.
Medicine (Baltimore). 2020 Apr;99(16):e19797. doi: 10.1097/MD.0000000000019797. PMID: 32311994; PMCID: PMC7440247.

Not only disease activity but also chronic hypertension and overweight are determinants of pregnancy outcomes in patients with systemic lupus erythematosus. Normand G et al.
Lupus. 2019 Apr;28(4):529-537. doi: 10.1177/0961203319832097. Epub 2019 Feb 24. PMID: 30799679.

EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Andreoli L et al.
Ann Rheum Dis. 2017 Mar;76(3):476-485. doi: 10.1136/annrheumdis-2016-209770. Epub 2016 Jul 25. PMID: 27457513; PMCID: PMC5446003.

Influence of disease activity and medications on offspring birth weight, pre-eclampsia and preterm birth in systemic lupus erythematosus: a population-based study. Skorpen CG et al. Ann Rheum Dis. 2018 Feb;77(2):264-269. doi: 10.1136/annrheumdis-2017-211641. Epub 2017 Nov 1. PMID: 29092851.

Disease Activity During Pregnancy and the First Year Postpartum in Women With Systemic Lupus Erythematosus.
Götestam Skorpen C et al. Arthritis Care Res (Hoboken). 2017 Aug;69(8):1201-1208. doi: 10.1002/acr.23102. Epub 2017 Jul 10. PMID: 27696790.

Artrittsykdommer

Caesarean section in women with axial spondyloarthritis and psoriatic arthritis: a population-based study. Götestam Skorpen C, Lydersen S, Salvesen KÅ, Koksvik HSS, Jakobsen B, Wallenius M. RMD Open. 2023 Mar;9(1):e002760. doi: 10.1136/rmdopen-2022-002760. PMID: 36863750; PMCID: PMC9990672.

Pregnancy and neonatal outcomes in women with axial spondyloarthritis: pooled data analysis from the European Network of Pregnancy Registries in Rheumatology (EuNeP).
Meissner, Y., Strangfeld, A., Molto, A., Forger, F., Wallenius, M., Costedoat-Chalumeau, N., Bjørngaard, H., Couderc, M., Flipo, R. M., Guettrot-Imbert, G., Haase, I., Jakobsen, B., Koksvik, H. S. S., Richez, C., Sellam, J., Weiß, A., Zbinden, A., & Fischer-Betz, R. (2022). Ann Rheum Dis. https://doi.org/10.1136/ard-2022-222641

Modern treatment approach results in low disease activity in 90% of pregnant rheumatoid arthritis patients: the PreCARA study. Smeele HT, Röder E, Wintjes HM, Kranenburg-van Koppen LJ, Hazes JM, Dolhain RJ. Ann Rheum Dis. 2021 Jul;80(7):859-864. doi: 10.1136/annrheumdis-2020-219547. Epub 2021 Feb 10. PMID: 33568387; PMCID: PMC8237196.

Pregnancy outcomes in women with ankylosing spondylitis: a scoping literature and methodological review. Mokbel A, Lawson DO, Farrokhyar F.
Clin Rheumatol. 2021 Jan 19. doi: 10.1007/s10067-021-05588-9. Epub ahead of print. PMID: 33464430.

Psoriatic Arthritis Disease Activity During and After Pregnancy: A Prospective Multicenter Study.
Ursin K et al. Arthritis Care Res (Hoboken). 2019 Aug;71(8):1092-1100. doi: 10.1002/acr.23747. Epub 2019 Jul 9. PMID: 30192071.

Disease activity during and after pregnancy in women with axial spondyloarthritis: a prospective multicentre study.
Ursin K et al. Rheumatology (Oxford). 2018 Jun 1;57(6):1064-1071. doi: 10.1093/rheumatology/key047. PMID: 29554329.

Disease Activity of Juvenile Idiopathic Arthritis during and after Pregnancy: A Prospective Multicenter Study.
Ursin K et al. J Rheumatol. 2018 Feb;45(2):257-265. doi: 10.3899/jrheum.161410. Epub 2017 Dec 1. PMID: 29196380.

Vaskulitter

A comprehensive guide for managing the reproductive health of patients with vasculitis. Sims, C., & Clowse, M. E. B. (2022). Nat Rev Rheumatol, 1-13. https://doi.org/10.1038/s41584-022-00842-z. PMID: 36192559.

Pregnancy Outcomes in Systemic Vasculitides.
Ross C et al. Curr Rheumatol Rep. 2020 Aug 26;22(10):63. doi: 10.1007/s11926-020-00940-5. PMID: 32845412; PMCID: PMC7448704.

Takayasu Arteritis and Pregnancy: A Population-Based Study on Outcomes and Mother/Child-Related Concerns.
Gudbrandsson B et al. Arthritis Care Res (Hoboken). 2017 Sep;69(9):1384-1390. doi: 10.1002/acr.23146. Epub 2017 Aug 8. PMID: 27813289.

Pregnancy and vasculitis: a systematic review of the literature.
Gatto M et al. Autoimmun Rev. 2012 May;11(6-7):A447-59. doi: 10.1016/j.autrev.2011.11.019. Epub 2011 Dec 3. PMID: 22155197.

Antifosfolipidsyndrom

EULAR recommendations for the management of antiphospholipid syndrome in adults. Tektonidou MG et al. Ann Rheum Dis. 2019 Oct;78(10):1296-1304. doi: 10.1136/annrheumdis-2019-215213. Epub 2019 May 15. PMID: 31092409.

Management of antiphospholipid syndrome.
Uthman I et al. Ann Rheum Dis. 2019 Feb;78(2):155-161. doi: 10.1136/annrheumdis-2018-213846. Epub 2018 Oct 3. PMID: 30282668.

Fertilitet

Factors associated with time to pregnancy in women with axial spondyloarthritis: A registry-based multicenter study.
Ursin K et al. Arthritis Care Res (Hoboken). 2020 Apr 30. doi: 10.1002/acr.24233. Epub ahead of print. PMID: 32353185.

Decreased chance of a live born child in women with rheumatoid arthritis after assisted reproduction treatment: a nationwide cohort study.
Nørgård BM et al. Ann Rheum Dis. 2019 Mar;78(3):328-334. doi: 10.1136/annrheumdis-2018-214619. Epub 2019 Jan 12. PMID: 30636215.

Women with systemic lupus erythematosus get pregnant more easily than women with rheumatoid arthritis.
Götestam Skorpen C et al. Rheumatology (Oxford). 2018 Jun 1;57(6):1072-1079. doi: 10.1093/rheumatology/key049. PMID: 29554346.